sch 16134 has been researched along with triazolam in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 7 (29.17) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mahowald, MW; Walsh, JK | 1 |
| Roehrs, TA; Roth, T | 1 |
| Bixler, EO; Jacoby, JA; Kales, A; Kales, JD; Soldatos, CR | 1 |
| Ellinwood, EH; Heatherly, DG; Nikaido, AM | 1 |
| Ellinwood, EH; Nikaido, AM | 1 |
| Lader, M; Lee, A | 1 |
| Gevins, AS; Ragsdale, SD; Stone, RK | 1 |
| Bixler, EO; Kales, A; Manfredi, RL; Niklaus, DE; Soldatos, CR; Vela-Bueno, A | 1 |
| Cooper, SJ | 1 |
| Csima, A; Mamelak, M; Price, V | 1 |
| Bixler, EO; Kales, A; Soldatos, CR; Vela-Bueno, A | 1 |
| Carskadon, M; Dement, W; Seidel, W | 1 |
| Bixler, EO; Kales, A; Kales, JD; Soldatos, CR | 1 |
| Altamura, AC; Gianetti, S; Mauri, MC; Pugnetti, L | 1 |
| Landy, DA | 1 |
| Anderer, P; Brandstätter, N; Frey, R; Grünberger, J; Klösch, G; Mandl, M; Saletu, B; Wetter, T; Zeitlhofer, J | 1 |
| Scharf, MB | 1 |
| Ali, JA; Rush, CR | 1 |
| Kamijima, K; Mimura, M; Nakagome, K; Okajima, Y; Otsubo, T; Shinoda, J; Takahashi, T | 1 |
| Araki, N; Cui, Y; Fujimura, A; Harada, K; Kawaguchi, A; Ohmori, M; Sugimoto, K; Tsuruoka, S | 1 |
| Hasegawa, C; Hayashida, M; Kurosaki, K; Ohno, Y; Shinozuka, T; Tanaka, E; Terada, M | 1 |
4 review(s) available for sch 16134 and triazolam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A review of the safety profiles of benzodiazepine hypnotics.
Topics: Aged; Anti-Anxiety Agents; Benzodiazepines; Central Nervous System; Flurazepam; Half-Life; Humans; Hypnotics and Sedatives; Middle Aged; Psychomotor Performance; Sleep; Sleep Initiation and Maintenance Disorders; Temazepam; Triazolam | 1991 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam | 1985 |
Behavioral side effects of benzodiazepine hypnotics.
Topics: Amnesia; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Flurazepam; Humans; Hypnotics and Sedatives; Psychomotor Disorders; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Substance-Related Disorders; Triazolam | 1985 |
10 trial(s) available for sch 16134 and triazolam
| Article | Year |
|---|---|
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam | 1985 |
Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Cognition; Humans; Male; Psychomotor Performance; Triazolam | 1987 |
Tolerance and rebound during and after short-term administration of quazepam, triazolam and placebo to healthy human volunteers.
Topics: Adult; Anti-Anxiety Agents; Arousal; Attention; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Electroencephalography; Evoked Potentials; Female; Humans; Male; Psychological Tests; Psychomotor Performance; Sleep Stages; Triazolam | 1988 |
Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.
Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Half-Life; Humans; Middle Aged; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam | 1986 |
Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Sleep Wake Disorders; Substance Withdrawal Syndrome; Triazolam | 1993 |
Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Topics: Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Male; Polysomnography; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance Withdrawal Syndrome; Triazolam | 1994 |
Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
Topics: Anti-Anxiety Agents; Benzodiazepines; Circadian Rhythm; Double-Blind Method; Drug Administration Schedule; Humans; Hypnotics and Sedatives; Placebos; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam | 1993 |
A follow-up study of the acute behavioral effects of benzodiazepine-receptor ligands in humans: comparison of quazepam and triazolam.
Topics: Adult; Anti-Anxiety Agents; Behavior; Benzodiazepines; Cognition; Cross-Over Studies; Female; Follow-Up Studies; GABA Modulators; Humans; Learning; Ligands; Male; Mental Recall; Middle Aged; Psychomotor Performance; Receptors, GABA-A; Surveys and Questionnaires; Triazolam | 1999 |
Comparison of hangover effects among triazolam, flunitrazepam and quazepam in healthy subjects: a preliminary report.
Topics: Activities of Daily Living; Adult; Anti-Anxiety Agents; Benzodiazepines; Cross-Over Studies; Fatigue; Female; Flunitrazepam; Humans; Hypnotics and Sedatives; Male; Single-Blind Method; Sleep Wake Disorders; Triazolam | 2003 |
Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam.
Topics: Adult; Analysis of Variance; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzodiazepines; Beverages; Chromatography, High Pressure Liquid; Citrus paradisi; Cross-Over Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Food-Drug Interactions; Half-Life; Humans; Hypnotics and Sedatives; Male; Metabolic Clearance Rate; Time Factors; Triazolam | 2006 |
11 other study(ies) available for sch 16134 and triazolam
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Avoiding the blanket approach to insomnia. Targeted therapy for specific causes.
Topics: Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Diagnosis, Differential; Estazolam; Flurazepam; Humans; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorders; Temazepam; Triazolam | 1991 |
Comparative pharmacodynamics of benzodiazepines.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Humans; Kinetics; Lorazepam; Male; Psychomotor Performance; Triazolam | 1987 |
Differentiating the effects of three benzodiazepines on non-REM sleep EEG spectra. A neural-network pattern classification analysis.
Topics: Adult; Algorithms; Anti-Anxiety Agents; Benzodiazepines; Cerebral Cortex; Electroencephalography; Evoked Potentials; Flurazepam; Humans; Male; Nerve Net; Nervous System; Signal Processing, Computer-Assisted; Sleep Stages; Triazolam | 1988 |
Hyperphagic and anorectic effects of beta-carbolines in a palatable food consumption test: comparisons with triazolam and quazepam.
Topics: Animals; Anti-Anxiety Agents; Appetite Depressants; Benzodiazepines; Carbolines; Dose-Response Relationship, Drug; Eating; Male; Pyrazoles; Rats; Triazolam | 1986 |
Effects of quazepam and triazolam on the sleep of chronic insomniacs: a comparative 25-night sleep laboratory study.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Drug Tolerance; Female; Humans; Male; Middle Aged; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Time Factors; Triazolam | 1985 |
Daytime alertness, insomnia, and benzodiazepines.
Topics: Adult; Anti-Anxiety Agents; Arousal; Benzodiazepines; Double-Blind Method; Flurazepam; Humans; Lorazepam; Male; Oxazepam; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Sleep Stages; Triazolam; Wakefulness | 1982 |
Early morning insomnia with rapidly eliminated benzodiazepines.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Half-Life; Humans; Midazolam; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam | 1983 |
Article questioned.
Topics: Anti-Anxiety Agents; Benzodiazepines; Humans; Peer Review; Periodicals as Topic; Placebos; Research Design; Sleep Initiation and Maintenance Disorders; Terminology as Topic; Triazolam; Writing | 1994 |
Analysis of quazepam and its metabolites in human urine by gas chromatography-mass spectrometry: application to a forensic case.
Topics: Benzodiazepines; Benzodiazepinones; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Hypnotics and Sedatives; Male; Solid Phase Extraction; Substance Abuse Detection; Triazolam | 2013 |